YPEL5 was found to be inhibited by METTL3-m6A (N6-methyladenosine)-YTHDF2 axis in colorectal cancer, promoting the growth and metastasis of tumor (Zhou et al., 2021). Here, YTHDF2 is linked to neoplasm.